0% found this document useful (0 votes)
96 views49 pages

Quality Assurance and Quality Control in The Clinical Laboratory

Uploaded by

MarlonZuniga
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
96 views49 pages

Quality Assurance and Quality Control in The Clinical Laboratory

Uploaded by

MarlonZuniga
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 49

Chapter 13

Quality Assurance and Quality


Control in the Clinical Laboratory

Copyright © 2016 by Elsevier, Inc. All rights reserved. 1


Chapter 13 Objectives

At the end of this chapter, the reader should be


able to do the following:
 Define the following terms: quality control material,
outlier, shift, trend, random error, and systematic error.
 Plot quality control results on a Levey-Jennings chart.
 Evaluate quality control results for shifts and trends.
 Evaluate quality control results and determine, using
Westgard multirules, whether the results are
acceptable.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 2


Basic Quality Assurance Concepts
 Quality assurance
 Process in which instruments and methodologies
are monitored to ensure an accurate result
 Monitoring of any activity that is associated with a
laboratory result
• Preanalytical activities: occur before the sample
reaches the laboratory
• Analytical activities: occur in the laboratory and directly
deal with the analysis of the sample
• Postanalytical activities: activities after the analysis is
performed
 Techniques include taking random samples
throughout activity phases.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 3


Quality Control Material

 Material that is analyzed along with patient


specimens should be treated the same as
patient specimens.
 Should be of the same matrix as the patient
sample
 Matrix: the chemical and physical characteristics
of the material that contains the analytes to be
measured

Copyright © 2016 by Elsevier, Inc. All rights reserved. 4


Quality Control Analysis

 “What is an acceptable limit for my quality


control material result?”
 If the quality control (QC) result is outside of the
acceptable limit established by the laboratory, the
patient results should not be reported until the
problem is solved.
No patient results should be reported until the
method is “in control.”

Copyright © 2016 by Elsevier, Inc. All rights reserved. 5


Quality Control Analysis (Cont.)

Probabilities associated with standard deviations


(SDs)
Copyright © 2016 by Elsevier, Inc. All rights reserved. 6
Errors That Cause a Method To
Be Out of Control
 Out of control: a result outside of established
QC range
 Two main reasons why a method is out of
control:
 Random error
• Occurs solely by chance
• Related to the precision of the method
 Systematic error
• All samples affected
• May produce a “bias” in the method
• Related to the accuracy of the method

Copyright © 2016 by Elsevier, Inc. All rights reserved. 7


Levey-Jennings Charts
 CLIA ’88 and good laboratory practice
require:
 At least 2 QC materials/day for each nonwaived
method
• To ensure accurate and reliable patient results
• If equivalent quality control (EQC) is not the method
used
 The results of the quality control material
should be analyzed to determine whether the
method is “in control” before patient results
are reported.
 To analyze each control value, plot the value
on a Levey-Jennings control chart.
Copyright © 2016 by Elsevier, Inc. All rights reserved. 8
Levey-Jennings Charts (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 9


Levey-Jennings Charts (Cont.)

EXAMPLE:
 Three levels of control are run daily on an automated
hematology analyzer in a physician’s office laboratory.
 The mean for the “normal” level is 15 mg/dL with an SD of
1.5 mg/dL.
 What will the Levey-Jennings chart look like if a
technician plotted hemoglobin results obtained from the
“normal” level of QC material over a 5-day period?

Copyright © 2016 by Elsevier, Inc. All rights reserved. 10


Levey-Jennings Charts (Cont.)
 The hemoglobin results that were obtained are:
 Day 1 = 13 mg/dL
 Day 2 = 12.5 mg/dL
 Day 3 = 16.0 mg/dL
 Day 4 = 15.5 mg/dL
 Day 5 = 14 mg/dL
 Because the mean for the “normal” level is 15
mg/dL with a SD of 1.5 mg/dL:
 +/- 1 SD = 13.5 to 16.5 mg/dL
 +/- 2 SD = 12 to 18 mg/dL
 +/- 3 SD = 10.5 to 19.5 mg/dL

Copyright © 2016 by Elsevier, Inc. All rights reserved. 11


Levey-Jennings Charts (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 12


Levey-Jennings Charts (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 13


Levey-Jennings Charts (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 14


Shift and Trends

 Shift
 Occurs when QC results are all distributed on one
side of the mean for 5 to 7 consecutive days
 Occurs because of systematic error
 Cause must be found and corrected because the
method is “out of control”

Copyright © 2016 by Elsevier, Inc. All rights reserved. 15


Shift and Trends (Cont.)

Levey-Jennings chart demonstrating a shift


Copyright © 2016 by Elsevier, Inc. All rights reserved. 16
Shift and Trends (Cont.)

 Trend
 Occurs when QC results either decrease or increase
consistently over a period of 5 to 7 days
 Is caused by a systematic error
 Tends to occur more slowly
 Cause must be found and corrected

Copyright © 2016 by Elsevier, Inc. All rights reserved. 17


Shift and Trends (Cont.)

Levey-Jennings chart demonstrating a trend


Copyright © 2016 by Elsevier, Inc. All rights reserved. 18
Quality Control Assessment
 Each laboratory is responsible for establishing its own
criteria for acceptance or rejection of quality control
results
 CLIA ’88 requires a minimum of two levels of controls for
most methods each day unless EQC or new voluntary,
customizable IQCP is used
 At minimum, QC procedures must follow manufacturer’s
instructions, current CLIA QC regulations or ICQP
 IQCP has three parts:
 Risk assessment for identification and evaluation of potential
errors and failures in testing process
 Quality control plan (QCP) describing lab’s control of quality for
a particular test method
 Quality assessment plan (QA) written to ensure quality of lab
results
Copyright © 2016 by Elsevier, Inc. All rights reserved. 19
Westgard Multirules
 Set of quality control rules to interpret quality
control results in the clinical laboratory
 The quality control result is first assessed against the
first rule, or “warning rule.”
 If a rule is not broken, the next rule is assessed.
 If, at any point, a rule, except for the warning rule, is
violated, the result is rejected, and the method may be
“out of control.”
 The large number (1, 2, 4, or 10) = the number of QC
results that are out of control
 The subscript numbers = the SDs that have been
violated
• For example, 12S means 1 QC value has violated 2 SD

Copyright © 2016 by Elsevier, Inc. All rights reserved. 20


Westgard Multirules (Cont.)

QC rule flow chart for two levels of controls


Copyright © 2016 by Elsevier, Inc. All rights reserved. 21
Westgard Multirules (Cont.)

 The warning rule or 12S rule


 The rule is violated if either of the 2 controls exceeds 2
SD from the mean in either a positive or negative
direction.
 When this rule is violated, the other rules are applied.
 If the quality control results do not violate any other
rule, even if one of the two results violates the 12S rule,
the control results are accepted.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 22


Westgard Multirules (Cont.)

EXAMPLE:
 The following are two Levey-Jennings charts for level 1
and level 2 glucose control. Notice the results obtained
for both levels on day 5.
 Do the results violate any Westgard multirules?

Copyright © 2016 by Elsevier, Inc. All rights reserved. 23


Westgard Multirules (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 24


Westgard Multirules (Cont.)
 On day 5, the result for the level 1 control
exceeded +2 SD but was within +3 SD.
 The result for the level 2 control was within 2 SD
 If only one of the two quality control results
exceeded +2 SD, the 12S warning rule was
violated.
 If no other rule was violated on that day, the run
can be accepted.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 25


Westgard Multirules (Cont.)

 The 13S rule


 Violated when the result of one of the two quality
control results is outside of 3 SD
 If a result is outside of 3 SD:
• Less than 1% chance that the result is an accurate result
• 99.7% chance that the result is an outlier
 When either of the QC results violates this rule:
• The result is rejected
• Run is out of control and should not be accepted
 Usually caused by a random error

Copyright © 2016 by Elsevier, Inc. All rights reserved. 26


Westgard Multirules (Cont.)

EXAMPLE:
 The following are two Levey-Jennings charts for a level
1 and level 2 cholesterol control. Notice the result for
day 7.
 What rule, if any, is violated?

Copyright © 2016 by Elsevier, Inc. All rights reserved. 27


Westgard Multirules (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 28


Westgard Multirules (Cont.)
 On day 7, the result for the level 2 cholesterol
control was 360 mg/dL.
 The result exceeded the +3 SD range for this
cholesterol control.
 By default, if a result exceeds ±3 SD, it will
violate the 12S warning rule.
 This sets off the sequential chain of analysis of
the rest of the Westgard multirules.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 29


Westgard Multirules (Cont.)
 The next rule to analyze after a result has
broken the warning rule is the 13S rule.
 The level 2 cholesterol control has violated this
rule.

The run should not be accepted, and the


control should be repeated.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 30


Westgard Multirules (Cont.)

 The 22S rule


 Can be violated in two ways:
• If both control results are either >2 SD or <2 SD from the
mean
• If one of the control results also exceeded 2 SD in the
same manner in the previous run
 Violated because of a systematic error

Copyright © 2016 by Elsevier, Inc. All rights reserved. 31


Westgard Multirules (Cont.)

EXAMPLE:
 The following are two quality control charts for

level 1 and level 2 serum creatinine. Notice the


quality control results for day 10.
 Is a Westgard rule violated on that day, and if

so, which one?

Copyright © 2016 by Elsevier, Inc. All rights reserved. 32


Westgard Multirules (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 33


Westgard Multirules (Cont.)

 On day 10:
 Both the level 1 and level 2 creatinine quality
control results are >2 SD from the mean.
 The 12S warning rule is violated for level 1 (as well
as level 2).
 This triggers the evaluation of the other rules.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 34


Westgard Multirules (Cont.)
 13S rule: Neither control value violates the 13S
rule.
 22S rule: Both control levels exceed +2 SD from
the mean, so this is violated.
 The error must be found and corrected because
the method is “out of control.”

No patient results should be reported until the


error is corrected and the control results are
acceptable.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 35


Westgard Multirules (Cont.)

 The R4S rule


 Violated when the difference, or range, between the
two control values within a run is >4 SD
 Violated when both control values violate the 12S rule
but in opposite directions
• One control is elevated higher than the +2 SD limit, and the
other is less than the 2 SD limit.
 Usually violated caused by a random error

Copyright © 2016 by Elsevier, Inc. All rights reserved. 36


Westgard Multirules (Cont.)

EXAMPLE:
 Two levels of quality control for total serum

amylase are charted on the following Levey-


Jennings charts.
 Notice the control results for day 12. Are any

quality control rules violated on that day?

Copyright © 2016 by Elsevier, Inc. All rights reserved. 37


Westgard Multirules (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 38


Westgard Multirules (Cont.)
 On day 12, the control result for level 1 was 2.1
above the mean.
 Violates the 12S rule
 Triggers review of the other rules
 The control result for level 2 was 2.2 less than
the mean.
 The spread, or range, between the 2 control results is
4.3.
 This violates the R4S rule.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 39


Westgard Multirules (Cont.)

 The 41S rule


 Can be violated in two ways:
• One level of control: four consecutive results fall on the same
side of the mean and exceed ±1 SD of the mean
• Two levels of control: when both levels of control for 2 runs in
a row exceed ±1 SD from the mean
 Somewhat like the rule for a shift:
• The four results are on the same side of the mean (which is
statistically unlikely) and exceed 1 SD (but not 2 SD).

Copyright © 2016 by Elsevier, Inc. All rights reserved. 40


Westgard Multirules (Cont.)

EXAMPLE:
 Two levels of control for total bilirubin are charted on
the following Levey-Jennings chart.
 Do any of the control results violate any Westgard
rules? If so, which one(s)?

Copyright © 2016 by Elsevier, Inc. All rights reserved. 41


Westgard Multirules (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 42


Westgard Multirules (Cont.)
 On day 4, the level 1 control violated the 41S rule.
 The control result for that day was the fourth
result to fall on the same side of the mean and
exceed +1 SD of the mean.

A systematic error is most likely the cause, and


the run is rejected until the problem is corrected.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 43


Westgard Multirules (Cont.)

 The 10x rule


 Can be violated in two ways:
• In 10 consecutive runs for one level of quality control, the
results are all on the same side of the mean
 The 10 results can fall in either a positive or negative direction.
• When the results are all on the same side of the mean for
both levels of control for 5 days (or 5 runs) in a row

Copyright © 2016 by Elsevier, Inc. All rights reserved. 44


Westgard Multirules (Cont.)

EXAMPLE:
 The following are the Levey-Jennings charts of

two levels of control for serum total protein.


 Do the control results violate any Westgard

rules? If so, which one(s)?

Copyright © 2016 by Elsevier, Inc. All rights reserved. 45


Westgard Multirules (Cont.)

Copyright © 2016 by Elsevier, Inc. All rights reserved. 46


Westgard Multirules (Cont.)
 The level 2 control results violate the 10x rule on
day 15.
 Level 1 control results do not violate any of the
Westgard rules.
 A systematic error is occurring with the level 2
control.

The patient results should not be reported until


the error is corrected and the QC results are
acceptable.
Copyright © 2016 by Elsevier, Inc. All rights reserved. 47
Westgard Multirules (Cont.)
 Westgard rules for three levels of control
 The (2 of 3)2S rule:
• Violated when two of the three levels of control exceed 2 SD
in the same direction
 The 9x rule:
• Violated when nine results in a row for a single control all fall
on the same side of the mean
• Violated when for three runs, the results for all three levels of
control all fall on the same side of the mean
 The 41S rule is not used when the levels of control are
used.

Copyright © 2016 by Elsevier, Inc. All rights reserved. 48


Westgard Multirules (Cont.)

QC rule flow chart for three levels of control


Copyright © 2016 by Elsevier, Inc. All rights reserved. 49

You might also like